May 8, 2026 — Strawberry Fields REIT (NYSE AMERICAN: STRW) reported first-quarter 2026 results showing growth in key operating metrics, with FFO rising to $20. 9 million, or $0.
May 8, 2026 — Strawberry Fields REIT (NYSE AMERICAN: STRW) announced that its board of directors has declared a quarterly cash dividend of $0. 17 per common share.
May 8, 2026 — This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.
May 8, 2026 — KALA BIO (NASDAQ: KALA) implemented a 1-for-50 reverse stock split of its common stock, effective at 4:05 p. m.
May 8, 2026 — This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.
May 8, 2026 — American Fusion (OTC: AMFN) reported that fabrication partners in Odessa, Texas, have completed the structural frame for the company’s 5MW Texatron(TM) pre-production unit, marking a key engineering milestone as the fusion energy developer moves from prototype development toward integrated system assembly and controlled testing. The unit is undergoing additional integration work before shipment to American Fusion’s Fort Worth facility, where the company plans to begin system testing, diagnostics validation and safety evaluations following regulatory review and site readiness preparations.
May 7, 2026 — Cannabis rescheduling in the U. S.
May 7, 2026 — This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.
May 7, 2026 — This article has been disseminated on behalf of Cizzle Brands Corporation and may include paid advertising. Cizzle Brands (Cboe Canada: CZZL) (OTCQB: CZZLF) (Frankfurt: 8YF) announced the closing of a US$6.
May 7, 2026 — Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.
May 7, 2026 — SKYX Platforms (NASDAQ: SKYX), a smart home and AI platform technology company, announced it will host a corporate update conference call on May 11, 2026, at 4:30 p. m.
May 7, 2026 — Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, unveiled the next phase of development for its withZeta. ai platform, including planned launches of ZetaSwarm(TM), an autonomous multi-agent AI research system, ZetaOmics(TM), a computational biology and multi-omic analytics toolkit, and new enterprise-grade capabilities designed to support institutional oncology research and drug discovery workflows.
May 7, 2026 — Oragenics (NYSE American: OGEN) and Sigyn Therapeutics Inc. (OTCQB: SIGY) announced the signing of a letter of intent under which Oragenics expects to obtain an exclusive license to develop and commercialize Sigyn’s CardioDialysis(TM) blood purification technology for traumatic brain injury and chronic neurodegenerative diseases, complementing Oragenics’ Phase IIa intranasal neurosteroid candidate ONP-002 in a proposed dual-modality approach targeting inflammation on both sides of the blood-brain barrier.
May 7, 2026 — The biotechnology industry is going through a transformation that is redefining how a company’s value is interpreted. While revenue has traditionally been highly associated with a company’s valuation, clinical-stage progression and a company’s probability of success are being increasingly factored into its valuation.
May 7, 2026 — Datavault AI (NASDAQ: DVLT) announced that management has begun evaluating a potential dividend spin-out of its Acoustic Sciences division into a standalone public company proposed to be named API Media, with the reserved Nasdaq ticker symbol “ADIO,” as the company seeks to separate its acoustic technologies and live events operations from its AI-driven data monetization business. The proposed transaction remains subject to board approval, definitive agreements, regulatory approvals and other closing conditions.
May 7, 2026 — Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire examining the accelerating adoption of service robotics across industries including healthcare, logistics and hospitality, highlighting the company’s focus on scalable AI-driven robotics systems and strategic collaborations as global demand for automation continues to expand. To view the full press release, visit https://ibn.
May 7, 2026 — Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, announced a strategic initiative to explore ibogaine-based therapeutics for traumatic brain injury and related neuropsychiatric conditions, including the filing of a provisional U. S.
May 7, 2026 — NextPlat (NASDAQ: NXPL, NXPLW) a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced that it will release its financial results for the first quarter ended March 31, 2026, on May 14, 2026. To view the full press release, visit: https://ibn.
May 7, 2026 — HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding the company’s launch footprint into Southern California and completing its initial targeted markets alongside New York metro, Dallas and South Florida as it advances commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology. To view the full press release, visit https://ibn.
May 7, 2026 — Perpetuals. com (NASDAQ: PDC), an AI-powered fintech company, announced the filing of a U.